Which of the following is given to treat thrombocytopenia secondary to anti-cancer therapy and is known to stimulate progenitor megakaryocytes: (A) Filgrastim, (B) Oprelvekin, (C) Erythropoietin, (D) Anagrelide
Answer is B. Ans. is 'b' i.e., Oprelvekin